“…We would like to thank Judith Muller, Jennifer Williamson, Rachel Schaefer, Karli Tyance-Hassel, Jennie Lee, Theresa Wells, Rosalyn Marcellais, and Garret Spargo for their assistance in organizing and facilitating this symposium and Sophie Nothstine for providing the traditional prayer to start our meeting. We would like to thank all participants for their input during this symposium: Joe 3 Frank Sacco, 3 Sarah Nash, 3 Matthew J. Olnes, 3 Karen Miernyk, 1 Dana Bruden, 1 Maya Ramaswamy, 1 Brian McMahon, 1,3 Karen J. Goodman, 4 Adam J. Bass, 5 Chin Hur, 6 Manami Inoue, 7 M. Constanza Camargo, 8 Soo-Jeong Cho, 9 Kalani Parnell, 3 Elizabeth Allen, 10 Tina Woods, 3 and Stephanie Melkonian. 11 1 Arctic Investigations Program, Division of Preparedness and Emerging Infections, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia; 2 University of Alaska Anchorage, Anchorage, Alaska; 3 Alaska Native Tribal Health Consortium, Anchorage, Alaska; 4 University of Alberta, Edmonton, Alberta, Canada; 5 Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; 6 Columbia University, New York, New York; 7 Center for Public Health Sciences, National Cancer Center, Tokyo, Japan; 8 Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 9 Seoul National University Hospital, Seoul, Korea; 10 This Symposium leader discloses the following: Adam J. Bass receives funding from Bayer, Merck, and Novartis and is a cofounder of Signet Therapeutics.…”